CLDN2 and Barrett esophagus: While others focused their analyses on NDBE biopsies2 or did not specify the respective BE stages,3 we performed scRNAseq experiments with biopsies corresponding to different BE stages.4 Our analysis identified two sets of marker genes that distinguish between BE with and without IM, and CLDN2 as a marker gene for dysplastic BE stages.